ERBB2 and cancer: After introducing the HERACLES diagnostic criteria for HER2/neu overexpressing cancers and integrating conventional procedures like IHC and FISH with newer techniques like NGS as well as CGS together make an accurate demonstration of HER2/neu status in CRC.